Efficacy trial of 4 weeks ingestion of MSHF001 food

Not Applicable

• Conditions: Healthy adults

• Registration Number: JPRN-UMIN000044985
• Lead Sponsor: Kao Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-30
• Study Completion: 2021-12-24
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

-Subjects who are hot flashes 7 times a day or more, or 50 times a week or more. -Subjects with Kupperman index of 44 or higher. -Subjects with systemic illness. -Subjects who are diagnosed as menopausal disorders. -Subjects who are under Hormone Replacement Therapy (HRT). -Subjects who are outpatients or were treated by doctor within a month. -Subjects who are antidepressants, anxiolytics, hypnotic sedatives, taking drugs that affect psychiatric symptoms. -Subjects who have taken drugs or supplements (products mainly made with equol, isoflavones, and polyphenol-rich) that affect menopausal symptoms from 4 weeks before the screening trial. -Subjects who have been taking drugs or prescription drugs that affect the trial since 4 weeks before the start of the screening trial. -Subjects who are pregnant or lactating, or planned to become pregnant in the near future. -Subjects with smoking habit. -Subjects with drinking habit in every days (Alcohol equivalent 20g/day or more). -Subjects who have significantly disrupted the rhythm of their lives during the study period. -Subjects who have possibilities for emerging allergy to the ingredients contained in the test food, subjects with allergies such as drug allergy. -Subjects who plan to participate in other surveys or clinical trials between the time of recruitment and the end of the trial. -Subjects or their families engaged in the manufacture of health foods or supplements , market research company. -Subjects judged not appropriate by the physician responsible for the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified